149 related articles for article (PubMed ID: 2962879)
1. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
[TBL] [Abstract][Full Text] [Related]
2. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats.
Tanimoto K; Tamminga CA; Chase TN
Eur J Pharmacol; 1987 Dec; 144(2):147-51. PubMed ID: 3325296
[TBL] [Abstract][Full Text] [Related]
3. Involvement of dopamine D1 receptors in the control of growth hormone secretion in the rat.
Bluet-Pajot MT; Mounier F; Durand D; Kordon C
J Endocrinol; 1990 Nov; 127(2):191-6. PubMed ID: 2250145
[TBL] [Abstract][Full Text] [Related]
4. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
Olianas MC; Onali P
J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
[TBL] [Abstract][Full Text] [Related]
5. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
6. Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion.
Rovescalli AC; Brunello N; Monopoli A; Ongini E; Racagni G
Eur J Pharmacol; 1987 Mar; 135(2):129-36. PubMed ID: 3556197
[TBL] [Abstract][Full Text] [Related]
7. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
Monti JM; Fernández M; Jantos H
Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
[TBL] [Abstract][Full Text] [Related]
8. D-1 dopamine receptor stimulation elevates plasma prolactin levels.
Saller CF; Salama AI
Eur J Pharmacol; 1986 Mar; 122(1):139-42. PubMed ID: 3007174
[TBL] [Abstract][Full Text] [Related]
9. Adenylate cyclase from sea urchin eggs is positively and negatively regulated by D-1 and D-2 dopamine receptors.
Carginale V; Capasso A; Madonna L; Borrelli L; Parisi E
Exp Cell Res; 1992 Dec; 203(2):491-4. PubMed ID: 1360904
[TBL] [Abstract][Full Text] [Related]
10. Assessment of jaw movements by magnetic sensor in relation to topographies of orofacial behaviour in freely moving rats: Studies with the dopamine D(1)-like receptor agonists SKF 83822 vs SKF 83959.
Fujita S; Kiguchi M; Kobayashi M; Kinsella A; Koshikawa N; Waddington JL
Eur J Pharmacol; 2010 Apr; 632(1-3):39-44. PubMed ID: 20122923
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Biochem Pharmacol; 1995 May; 49(9):1185-93. PubMed ID: 7763300
[TBL] [Abstract][Full Text] [Related]
12. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 1991 Sep; 202(2):273-6. PubMed ID: 1839386
[TBL] [Abstract][Full Text] [Related]
13. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 receptor analogues act centrally to stimulate prolactin secretion in ewes.
Curlewis JD; Clarke IJ; McNeilly AS
J Endocrinol; 1993 Jun; 137(3):457-64. PubMed ID: 8371076
[TBL] [Abstract][Full Text] [Related]
15. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
Saller CF; Salama AI
J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552
[TBL] [Abstract][Full Text] [Related]
16. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
[TBL] [Abstract][Full Text] [Related]
17. The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390.
Itoh Y; Beaulieu M; Kebabian JW
Eur J Pharmacol; 1984 Apr; 100(1):119-22. PubMed ID: 6144550
[TBL] [Abstract][Full Text] [Related]
18. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
19. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
Rouillard C; Bédard P; Falardeau P; Di Paolo T
Eur J Pharmacol; 1988 Nov; 157(2-3):125-33. PubMed ID: 2975996
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D-1 receptor agonist stimulation of prolactin secretion in man.
Fabbrini G; Braun A; Mouradian MM; Tamminga CA; Chase TN
J Neural Transm; 1988; 71(3):159-63. PubMed ID: 2965754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
